novo nordisk semaglutide copycat risk sues Hims & Hers over weight-loss drugs Novo Nordisk is proactively protecting

"It is paramount to remember that all weight-loss medications are recommended as an aid in the overall strategy that centers around a healthy meal plan and regular physical activity," says Dr

Semaglutide (Wegovy/Ozempic), which targets only the GLP-1 receptor, has over seven years of real-world data and more than 10 million patients worldwide

Subjects were stratified by diet into n = 11 vegans/vegetarians and n = 24 omnivorous subjects

Hydration is critical

Insulin, while sometimes used alongside semaglutide in clinical settings, requires careful blood sugar monitoring and dose adjustment to prevent dangerous hypoglycemia